Physician profile
Pedro Gr Teixeira
NPI 1851692784
$40,349.27
in general payments reported to CMS, 2019-2025
18 companies · $1,042 in 2025
The $1,042 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $12K · 2021: $134 · 2022: $1,888 · 2023: $1,902 · 2024: $3,641 · 2025: $1,042.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,401 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,600 · Travel and Lodging: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,401.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,600.00 |
| Travel and Lodging | $1,584.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $20,471.58 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $12,516.08 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Medtronic, INC. | $4,220.10 | 2022-2025 | Endurant Iis, Corevalve Evolut R, Hawkone |
| Boston Scientific Corporation | $1,303.51 | 2024-2025 | Versacross Access Solution, General - Vascular Intervention |
| Cook Medical LLC | $446.69 | 2020-2025 | Cook, Zenith Alpha, Zenith |
| Penumbra, INC. | $296.09 | 2024 | Penumbra System |
| Inari Medical, INC. | $252.73 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $227.76 | 2024 | Sapien 3 Ultra Resilia |
| Bolton Medical INC | $160.31 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Glidesheath Slender |
| Abiomed | $128.07 | 2024 | Impella |
| Lemaitre Vascular, INC. | $106.42 | 2020-2025 | Artegraft Vascular Graft |
| Reflow Medical INC | $52.01 | 2025 | |
| Integra Lifesciences Corporation | $44.46 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Prytime Medical Devices, INC. | $42.23 | 2021 | |
| Angiodynamics, INC. | $41.08 | 2024 | Auryon Laser System 100-120 Vac |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.81 | 2019 | |
| Dilon Technologies, INC. | $15.34 | 2025 | Hemoblast Bellows |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Teixeira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.